Related references
Note: Only part of the references are listed.Encapsulation of a Radiolabeled Cluster Inside a Fullerene Cage, 177LuxLu(3-x)N@C80: An Interleukin-13-Conjugated Radiolabeled Metallofullerene Platform
Michael D. Shultz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High H-1 Relaxivity
Chunying Shu et al.
BIOCONJUGATE CHEMISTRY (2009)
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
Achuthamangalam B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent
Chun-Ying Shu et al.
BIOCONJUGATE CHEMISTRY (2008)
Organophosphonate functionalized Gd@C82 as a magnetic resonance imaging contrast agent
Chun-Ying Shu et al.
CHEMISTRY OF MATERIALS (2008)
Imaging immune response in vivo:: Cytolytic action of genetically altered T cells directed to glioblastoma multiforme
Jelena Lazovic et al.
CLINICAL CANCER RESEARCH (2008)
Applications of emerging molecular technologies in glioblastoma multiforme
Hari R Kumar et al.
Expert Review of Neurotherapeutics (2008)
Hydrochalarones: A novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast
Darren K. MacFarland et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines
Ronald J. Bernardi et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents
Er-Yun Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle
Panos P. Fatouros et al.
RADIOLOGY (2006)
Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent:: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x
Chun-Ying Shu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2006)
Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Rα2-expressing contralateral tumors
Koji Kawakami et al.
CLINICAL CANCER RESEARCH (2006)
Synthesis and characterization of a new water-soluble endohedral metallofullerene for MRI contrast agents
CY Shu et al.
CARBON (2006)
Water-soluble gadofullerenes:: Toward high-relaxivity, pH-responsive MRI contrast agents
É Tóth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
A realistic brain tissue phantom for intraparenchymal infusion studies
ZJ Chen et al.
JOURNAL OF NEUROSURGERY (2004)
Gd@C60[C(COOH)2]10 and Gd@C60(OH)x:: Nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution
B Sitharaman et al.
NANO LETTERS (2004)
Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13R alpha 2
AB Madhankumar et al.
NEOPLASIA (2004)
First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent
RD Bolskar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Lanthanoid endohedral metallofullerenols for MRI contrast agents
H Kato et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
IL-13Rα2 is a glioma-restricted receptor for interleukin-13
A Mintz et al.
NEOPLASIA (2002)
Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents
M Mikawa et al.
BIOCONJUGATE CHEMISTRY (2001)
Share Paper
